Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study
- PMID: 26240760
- PMCID: PMC4512603
- DOI: 10.1155/2015/487159
Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study
Abstract
Depression and anxiety are reported to be prevalent in patients with MS, with prevalence rates ranging from 20% to 50%. Unfortunately, the rates, patterns, and risk factors are not well studied in our Middle East region, and, to our knowledge, not at all in UAE. Using standardized screening tools, we observed that 17% and 20% of 80 patients seen in MS clinic had scores consistent with major depression and anxiety disorders, respectively, at a rate that was not statistically different when compared to age and sex matched controls. None of the studied variables including duration of the disease, EDSS scores, age, gender, and the level of education had any significant correlation with the rates of both disorders. Almost two-thirds of the patients with scores consistent with major depression and anxiety were not on antidepressant and antianxiety medications.
Similar articles
-
Prevalence of depression and anxiety among patients with epilepsy attending the epilepsy clinic at Sheikh Khalifa Medical City, UAE: A cross-sectional study.Epilepsy Behav. 2015 Nov;52(Pt A):194-9. doi: 10.1016/j.yebeh.2015.09.008. Epub 2015 Oct 5. Epilepsy Behav. 2015. PMID: 26448591
-
Depression and anxiety as determinants of health-related quality of life in patients with multiple sclerosis - United Arab Emirates.Neurol Int. 2017 Dec 11;9(4):7343. doi: 10.4081/ni.2017.7343. eCollection 2017 Dec 11. Neurol Int. 2017. PMID: 29619159 Free PMC article.
-
Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study.Behav Neurol. 2015;2015:196373. doi: 10.1155/2015/196373. Epub 2015 Oct 21. Behav Neurol. 2015. PMID: 26576071 Free PMC article.
-
Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis.J Neurol Sci. 2017 Jan 15;372:331-341. doi: 10.1016/j.jns.2016.11.067. Epub 2016 Nov 30. J Neurol Sci. 2017. PMID: 28017241 Review.
-
Anxiety, depression and impaired health-related quality of life are therapeutic challenges in patients with multiple sclerosis.Ment Illn. 2010 May 14;2(1):e5. doi: 10.4081/mi.2010.e5. eCollection 2010 Jan 25. Ment Illn. 2010. PMID: 25478088 Free PMC article. Review.
Cited by
-
The prevalence of major depression and generalized anxiety disorder in patients with multiple sclerosis in Saudi Arabia: a cross-sectional multicentered study.Front Psychiatry. 2023 Aug 29;14:1195101. doi: 10.3389/fpsyt.2023.1195101. eCollection 2023. Front Psychiatry. 2023. PMID: 37706033 Free PMC article.
-
Prevalence of anxiety, depression, and stress in patients with multiple sclerosis in Kermanshah-Iran: a cross-sectional study.BMC Psychiatry. 2020 Apr 15;20(1):166. doi: 10.1186/s12888-020-02579-z. BMC Psychiatry. 2020. PMID: 32295564 Free PMC article.
-
Psychosocial Correlates of Depression and Anxiety in the United Arab Emirates During the COVID-19 Pandemic.Front Psychiatry. 2020 Nov 10;11:564172. doi: 10.3389/fpsyt.2020.564172. eCollection 2020. Front Psychiatry. 2020. PMID: 33240122 Free PMC article.
-
Real-world experience of ocrelizumab in multiple sclerosis in an Arab population.J Drug Assess. 2021 Oct 19;10(1):106-113. doi: 10.1080/21556660.2021.1989193. eCollection 2021. J Drug Assess. 2021. PMID: 34692185 Free PMC article.
-
Containing COVID-19 risk in the UAE: Mass quarantine, mental health, and implications for crisis management.Risk Hazards Crisis Public Policy. 2022 Mar;13(1):9-27. doi: 10.1002/rhc3.12237. Epub 2021 Sep 13. Risk Hazards Crisis Public Policy. 2022. PMID: 34909109 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources